Great find puddle.
i know the gears are currently grinding slowly from a investment point of view, but if we look at it as stakeholders in a company we can see that Race is doing so much to make Zantrene an effective and useful anti cancer tool (and beyond).
as an investor, I dislike delays, but as someone who is interested and can see what this company is aiming to do with Zantrene, it is completely understandable as we can see how busy these guys are.
if the board were skeptical about Zantrene being effective as an FTO, I doubt they'd be spending money on different ways to inject a dudd therapeutic...
Ann: Preclinical & Clinical Programs Update, page-22
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.94 |
Change
0.055(2.92%) |
Mkt cap ! $330.4M | |||
| Open | High | Low | Value | Volume |
| $1.89 | $1.96 | $1.85 | $333.0K | 174.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3105 | $1.94 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.95 | 7574 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |